Albert Bourla is Chairman and Chief Executive Officer of Pfizer, one of the world’s leading pharmaceutical companies. Albert is also a veterinarian. Known for his passion for leadership, he leads by the motto “Breakthroughs that transform patients’ lives.”
During his 25-year tenure with the company as CEO of Pfizer, he has evolved by serving with his diverse skillset. As for the current pandemic, Albert-led Pfizer has approved the first two trials for the COVID-19 vaccine and is in the third phase of trials. He believes that if things go according to plan, Americans can inject their vaccine before the end of the year.
Early life
Albert was born on October 21, 1961, in Thessaloniki, Greece and his parents were Jewish. Not much is known about his parents but it is known that he has no siblings. Ever since childhood, Albert had wanted to be a doctor, so after completing his high school diploma in 1979, he enrolled at Aristotle University in a local school in Thessaloniki, graduating with a Ph.D. away. in Biotechnology and Reproduction. Motivated by his early love for animals, he practiced as a veterinarian in Greece for a number of years. In addition, he was also interested in understanding the ability of technology to push the boundaries of science and medicine and pursued his career accordingly.
Albert Bourla career
In the early stages of his career, Albert practiced as a veterinarian in Greece. Later in 1993, he joined Pfizer’s Animal Health Division in Greece as Technical Director. In 2001 he was given responsibilities as Marketing Director for the US group in New York, given his significant work in improving animal health across Europe. After a few years, he was appointed vice president of business development and new product marketing. In 2006 he became Area President of Animal Health Europe, Asia, and the Middle East.
His enduring skills led him to General Manager for Pfizer’s established products business in 2010, where he oversaw the execution of strategies and tactics related to Pfizer’s patent-free portfolio. He played an important role as group president of Pfizer’s global vaccines, oncology, and consumer health businesses, leading them to greater heights. He later became Chief Operating Officer, where he oversaw the company’s business strategy, manufacturing, and global product development. In January 2019, he was appointed CEO of Pfizer.
Albert Bourla biography | |
|---|---|
| Real name | Albert Bourla |
| date of birth | October 21, 1961 |
| Age | 62 years |
| place of birth | Thessaloniki, Greece |
| nationality | Greek |
| job | Veterinarian & business tycoon |
| religion | Jews |
| sun sign | scale |
Physical Statistics | |
| height | in feet inches – 5′ 7” – in centimeters – 170 cm Approx |
| Weight | in kilograms – 63kg – in pounds – 138 pounds Approx |
| shoe size | 8 (USA) |
| Hair color | dark brown |
| eye color | dark brown |
| body type | average |
Albert Bourla family | |
| father | – |
| mother | – |
| sister | – |
| Brothers | – |
Qualification/Education | |
| school | – |
| University | Faculty of Veterinary Medicine, Aristotle University of Thessaloniki |
relationship status | |
| marital status | Married |
| who is Albert Bourla’s wife? | Myriam Alchanati Bourla |
| children | Two (a daughter & a son) |
Personal life
Albert is married to Myriam Alchanati Bourla and currently resides in Scarsdale, New York. He left his native Greece at the age of 34 and since then has lived in a total of 7 different cities and four different countries. The couple is blessed with two children, a son and a daughter.
Albert Bourla Net Worth
Albert Bourla, who is at the helm of Apex Pharmaceutical company, is believed to have a salary of nearly $18 million. He also owns a significant stake in Pfizer stock, which is currently valued at $37. His net worth is estimated at around $26.4 million.
Facts About Albert Bourla
- In his 25-year career at Pfizer, he has played no fewer than 10 roles for the company.
- In 2020, Institutional Investor magazine ranked Albert as America’s Best Pharmaceutical CEO.
- In addition to his services at Pfizer, he currently serves as a Trustee of the United States Council for International Business and is also a member of the Business Roundtable and Business Council.
- In his entire professional career, he has never worked with any company other than Pfizer.
- Albert was recognized by the Galien Foundation as an “Outstanding Greek Leader” for global pharmaceuticals.